The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

RSV and the common cold both cause symptoms of viral infection. Coughing tends to be more severe in RSV. Learn how RSV vs.

A new analysis from Imperial's human challenge study of COVID-19 has revealed subtle differences in the memory and cognition ...

Colorado's health department is working to get more information out to the public about circulating respiratory viruses. It’s ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

Experts predict a smaller winter COVID-19 wave due to summer surge immunity, but keep a close eye on mutated flu and potential human-to-human transmission ...

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green).

Respiratory virus infections in symptomatic and asymptomatic children upon hospital admission: new insights - Volume 4 Issue ...

Naobios and European Vaccine Initiative partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent Collaborat ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...